CLINICAL_TRIALS
trial_result
· 2022-08-03
Clinical Trial Update: Integration of HPV Vaccination and HPV-based Cervical Screening Into ARV Clinics: the H2VICTORY Trial [Phase 3]
Summary
Phase 3 trial evaluating integration of HPV vaccination and HPV-based cervical screening into ARV clinics (H2VICTORY).
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: International Agency for Research on Cancer | Conditions: HPV Infection | Phase 3 | Status: NOT_YET_RECRUITING